These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3731453)

  • 1. Decreased activity of carnosinase in serum of patients with chronic liver disorders.
    Bando K; Ichihara K; Toyoshima H; Shimotuji T; Koda K; Hayashi C; Miyai K
    Clin Chem; 1986 Aug; 32(8):1563-5. PubMed ID: 3731453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carnosinase activities in patients with alcoholic chronic skeletal muscle myopathy.
    Duane P; Peters TJ
    Clin Sci (Lond); 1988 Aug; 75(2):185-90. PubMed ID: 3409634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of C3 and cholinesterase in various diseases of the liver.
    Jorge AD; Sanchez D
    Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):19-25. PubMed ID: 1258598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced serum carnosinase activity in hypothyroidism.
    Bando K; Ichihara K; Shimotsuji T; Toyoshima H; Koda K; Hayashi C; Miyai K
    Ann Clin Biochem; 1986 Mar; 23 ( Pt 2)():190-4. PubMed ID: 3767265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum carnosinase activities in central nervous system disorders.
    Wassif WS; Sherwood RA; Amir A; Idowu B; Summers B; Leigh N; Peters TJ
    Clin Chim Acta; 1994 Feb; 225(1):57-64. PubMed ID: 8033354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between muscle fibre atrophy factor, plasma carnosinase activities and muscle RNA and protein composition in chronic alcoholic myopathy.
    Wassif WS; Preedy VR; Summers B; Duane P; Leigh N; Peters TJ
    Alcohol Alcohol; 1993 May; 28(3):325-31. PubMed ID: 7688966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human serum carnosinase: characterization, distinction from cellular carnosinase, and activation by cadmium.
    Lenney JF; George RP; Weiss AM; Kucera CM; Chan PW; Rinzler GS
    Clin Chim Acta; 1982 Aug; 123(3):221-31. PubMed ID: 7116644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood cholinesterase and hepatic function: a comparison with BSP and galactose elimination as well as serum albumin concentration].
    Gross O; Audetat V; Bircher J
    Schweiz Med Wochenschr; 1978 Sep; 108(36):1389-93. PubMed ID: 705294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorometric assay of human serum carnosinase activity in normal children, adults and patients with myopathy.
    Bando K; Shimotsuji T; Toyoshima H; Hayashi C; Miyai K
    Ann Clin Biochem; 1984 Nov; 21 ( Pt 6)():510-4. PubMed ID: 6517492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic and prognostic significance of cholinesterase (CHE) in chronic liver diseases].
    Magris D; Mottola A; Mian G; Minutillo S; Triolo L; D'Agnolo B
    Minerva Med; 1979 Feb; 70(6):483-7. PubMed ID: 431868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of serum cholinesterase in the diagnosis of chronic liver diseases].
    Dimov DM; Iordanova IU; Donchev P
    Vutr Boles; 1975; 14(4):40-6. PubMed ID: 1224594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prealbumin rather than albumin is a more sensitive indicator of acute liver disease.
    Yasmin MY; Aziz B; Nazim M; Madhavan RK
    Malays J Pathol; 1993 Dec; 15(2):147-50. PubMed ID: 8065177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocarnosinosis patients and great apes have a serum protein that cross-reacts with human serum carnosinase.
    Jackson MC; Lenney JF
    Clin Chim Acta; 1992 Jan; 205(1-2):109-16. PubMed ID: 1521330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between cholinesterase, prothrombin activity and albumin and the pathology of the liver].
    Zou Z; Xin S; Li B
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):349-51. PubMed ID: 11986723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum cholinesterase activity (CHE) in different classes of chronic liver diseases (author's transl)].
    Galanti B; Russo M; Nardiello S; Guarino F
    Quad Sclavo Diagn; 1978 Mar; 14(1):95-102. PubMed ID: 746115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans.
    Everaert I; Taes Y; De Heer E; Baelde H; Zutinic A; Yard B; Sauerhöfer S; Vanhee L; Delanghe J; Aldini G; Derave W
    Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1537-44. PubMed ID: 22496410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary kallikrein excretion in chronic liver disease and effect of indomethacin.
    Kawasaki H; Murawaki Y; Hirayama C
    Am J Gastroenterol; 1986 Jan; 81(1):67-70. PubMed ID: 3510529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic and resistance training do not influence plasma carnosinase content or activity in type 2 diabetes.
    Stegen S; Sigal RJ; Kenny GP; Khandwala F; Yard B; De Heer E; Baelde H; Peersman W; Derave W
    Am J Physiol Endocrinol Metab; 2015 Oct; 309(7):E663-9. PubMed ID: 26389600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance and practicability of Normotest in diagnosis of chronic liver diseases.
    Henning H; Yano M
    Scand J Gastroenterol Suppl; 1973; 19():119-23. PubMed ID: 4515634
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anabolic steroids and liver diseases].
    Wewalka F
    Wien Med Wochenschr; 1967 Mar; 117(12):293-9. PubMed ID: 4871957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.